Detalles de la búsqueda
1.
Heme catabolism by tumor-associated macrophages controls metastasis formation.
Nat Immunol
; 22(5): 595-606, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903766
2.
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.
J Transl Med
; 22(1): 223, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38429759
3.
Gut Microbiota, Metabolome, and Body Composition Signatures of Response to Therapy in Patients with Advanced Melanoma.
Int J Mol Sci
; 24(14)2023 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37511376
4.
A novel microRNA signature for the detection of melanoma by liquid biopsy.
J Transl Med
; 20(1): 469, 2022 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36243798
5.
Analysis of Sentinel Node Biopsy and Clinicopathologic Features as Prognostic Factors in Patients With Atypical Melanocytic Tumors.
J Natl Compr Canc Netw
; 18(10): 1327-1336, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33022642
6.
The non-small cell lung cancer immune landscape: emerging complexity, prognostic relevance and prospective significance in the context of immunotherapy.
Cancer Immunol Immunother
; 67(6): 1011-1022, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29516154
7.
Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.
J Neurooncol
; 138(3): 679-680, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29767306
8.
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors.
Eur J Immunol
; 46(2): 409-19, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26564811
9.
Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles.
BMC Cancer
; 14: 560, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25085576
10.
Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.
J Neurooncol
; 118(2): 305-312, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24696052
11.
Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors.
Front Immunol
; 15: 1336566, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38510242
12.
Immunotherapy for brain metastases and primary brain tumors.
Eur J Cancer
; 179: 113-120, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36521332
13.
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial.
Nat Commun
; 14(1): 5914, 2023 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37739939
14.
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis.
J Immunother Cancer
; 11(6)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37286305
15.
Phase II study of sorafenib in patients with relapsed or refractory lymphoma.
Br J Haematol
; 158(1): 108-19, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22571717
16.
Microfluidic devices modulate tumor cell line susceptibility to NK cell recognition.
Small
; 8(18): 2886-94, 2012 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-22761002
17.
A microRNA Prognostic Signature in Patients with Diffuse Intrinsic Pontine Gliomas through Non-Invasive Liquid Biopsy.
Cancers (Basel)
; 14(17)2022 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077842
18.
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy.
J Exp Clin Cancer Res
; 41(1): 325, 2022 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36397155
19.
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.
Blood
; 113(1): 18-27, 2009 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18809757
20.
Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell Carcinoma.
Front Oncol
; 11: 628324, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34221958